Status:

RECRUITING

Feasibility and Preliminary Results of the Efficacy of Blue-Blocking Glasses on Manic Symptoms in Bipolar Disorder

Lead Sponsor:

Centre Hospitalier St Anne

Conditions:

Bipolar 1 Disorder

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this clinical trial is to assess the feasibility of conducting a clinical trial of the use of blue-blocking glasses among patients with a type1 bipolar disorder, experiencing a manic episo...

Detailed Description

1. Patients' recruitment Patients experiencing a manic episode within the context of bipolar disorder type 1 will be recruited from the hospitalization department of sector G22 at GHU-Paris, located a...

Eligibility Criteria

Inclusion

  • Patient over 18 years old
  • Patient with a type 1 bipolar disorder presenting a manic episode according to the DSM-5 TR, with or without associated psychotic disorders.

Exclusion

  • Patient who did not agree to participate to the study
  • Patient unable to be informed or understand the course of the study
  • Patient with severe eye problem or with an history of trauma affecting the eyes
  • Pregnant or breastfeeding women
  • Patient in need of urgent care

Key Trial Info

Start Date :

July 19 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2026

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT07194278

Start Date

July 19 2024

End Date

September 1 2026

Last Update

September 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Secteur de psychiatrie adulte G22-G23-G24

Paris, France, France, 75018